Cargando…

A comparative analysis of ESM-1 and vascular endothelial cell marker (CD34/CD105) expression on pituitary adenoma invasion

OBJECTIVE: Pituitary adenomas are benign neoplasms that display invasive behavior—a characteristic traditionally associated with malignancy—through an ill-defined mechanism. The role of angiogenesis-related molecules in this pathological condition remains perplexing. Our purpose is to assess the imp...

Descripción completa

Detalles Bibliográficos
Autores principales:	Miao, Yanming, Zong, Miao, Jiang, Tao, Yuan, Xuesen, Guan, Shusen, Wang, Yisong, Zhou, Dabiao
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer US 2016
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4799238/ https://www.ncbi.nlm.nih.gov/pubmed/26809958 http://dx.doi.org/10.1007/s11102-015-0698-6

Ejemplares similares

Expression and clinical significance of CD31, CD34, and CD105 in pulmonary ground glass nodules with different vascular manifestations on CT
por: Guo, Chen-ran, et al.
Publicado: (2022)

An Immunohistochemical Survey to Evaluate the Expression of CD105 and CD34 in Ameloblastoma and Odontogenic Keratocyst
por: Jamshidi, Shokoofeh, et al.
Publicado: (2014)

Immunohistochemical Comparison of the Expression of CD34 and CD105 in Odontogenic Keratocyst and Dentigerous Cyst
por: Jamshidi, Shokoofeh, et al.
Publicado: (2017)

Phenotypic Characterization of Adherent Cells Population CD34+ CD90+ CD105+ Derived from Wharton’s Jelly
por: Walecka, Irena, et al.
Publicado: (2017)

CD105 is a more appropriate marker for evaluating angiogenesis in urothelial cancer of the upper urinary tract than CD31 or CD34
por: Miyata, Yasuyoshi, et al.
Publicado: (2013)

CD34 and CD105 Microvessels in Resected Bone Specimen May Implicate Wound Healing in MRONJ
por: Marcianò, Antonia, et al.
Publicado: (2021)

Histomorphological and Morphometric Evaluation of Microvessel Density in Nodal Non-Hodgkin Lymphoma Using CD34 and CD105
por: Kataria, Sant Prakash, et al.
Publicado: (2021)

CD105 is a prognostic marker and valid endothelial target for microbubble platforms in cholangiocarcinoma
por: Nair, Amit, et al.
Publicado: (2020)

CD34 Expression in the Stromal Cells of Alveolar Adenoma
por: De Rosa, Nicolina, et al.
Publicado: (2012)

Microvascular density of regenerative nodule to small hepatocellular carcinoma by automated analysis using CD105 and CD34 immunoexpression
por: Paschoal, Juliana Passos, et al.
Publicado: (2014)

Human Cardiac Mesenchymal Stromal Cells with CD105(+)CD34(-) Phenotype Enhance the Function of Post-Infarction Heart in Mice
por: Czapla, Justyna, et al.
Publicado: (2016)

CD105 Expression on CD34-Negative Spindle-Shaped Stromal Cells of Primary Tumor Is an Unfavorable Prognostic Marker in Early Breast Cancer Patients
por: Martinez, Leandro Marcelo, et al.
Publicado: (2015)

Practical ESM analysis
por: Robertson, Sue
Publicado: (2019)

Validation of the endothelial staining markers CD31 and CD34 in immunohistochemistry of the long saphenous vein.
por: Krishnamoorthy, B, et al.
Publicado: (2015)

CD31 and CD34 Expression as Immunohistochemical Markers of Endothelial Transdifferentiation in Human Cutaneous Melanoma
por: Pisacane, A. M., et al.
Publicado: (2007)

Correction: CD105 Expression on CD34-Negative Spindle-Shaped Stromal Cells of Primary Tumor Is an Unfavorable Prognostic Marker in Early Breast Cancer Patients
Publicado: (2015)

Identification of CD105 (endoglin) as novel risk marker in CLL
por: Greiner, Sarah M., et al.
Publicado: (2022)

CD34 marks angiogenic tip cells in human vascular endothelial cell cultures
por: Siemerink, Martin J., et al.
Publicado: (2012)

Expression of endoglin (CD105) in cervical cancer
por: Zijlmans, H J, et al.
Publicado: (2009)

Pathological significance and prognostic role of microvessel density, evaluated using CD31, CD34, and CD105 in prostate cancer patients after radical prostatectomy with neoadjuvant therapy
por: Miyata, Yasuyoshi, et al.
Publicado: (2015)

TLR Accessory Molecule RP105 (CD180) Is Involved in Post-Interventional Vascular Remodeling and Soluble RP105 Modulates Neointima Formation
por: Karper, Jacco C., et al.
Publicado: (2013)

CD105(+)CD90(+)CD13(+) identifies a clonogenic subset of adventitial lung fibroblasts
por: Kadefors, Måns, et al.
Publicado: (2021)

Correlations of Vascular Architecture and Angiogenesis with Pituitary Adenoma Histotype
por: Takano, Shingo, et al.
Publicado: (2014)

Evaluation of Endoglin (CD105) expression in pediatric rhabdomyosarcoma
por: Di Paolo, Virginia, et al.
Publicado: (2018)

CD105 (Endoglin) as negative prognostic factor in AML
por: Kauer, Joseph, et al.
Publicado: (2019)

Cardioprotective effects of erythropoietin in diabetic rats determined by CD34 and vascular endothelial growth factor levels
por: Oztas, Ýidem Melis, et al.
Publicado: (2020)

Endoglin (CD105) and VEGF as potential angiogenic and dissemination markers for colorectal cancer
por: Nogués, Ana, et al.
Publicado: (2020)

Evolution of a refractory prolactin-secreting pituitary adenoma into a pituitary carcinoma: report of a challenging case and literature review
por: Dai, Congxin, et al.
Publicado: (2021)

Distinctive effects of CD34- and CD133-specific antibody-coated stents on re-endothelialization and in-stent restenosis at the early phase of vascular injury
por: Wu, Xue, et al.
Publicado: (2015)

Osteoprotegerin Induces CD34(+) Differentiation in Endothelial Progenitor Cells
por: Boisson-Vidal, Catherine, et al.
Publicado: (2018)

Alterations in CD8(+) Tregs, CD56(+) Natural Killer Cells and IL-10 Are Associated With Invasiveness of Nonfunctioning Pituitary Adenomas (NFPAs)
por: Huang, Xinmei, et al.
Publicado: (2021)

Endoglin (CD105) is a more appropriate marker than CD31 for detecting microvessels in carotid artery plaques
por: Fukumitsu, Ryu, et al.
Publicado: (2013)

Pituitary Adenoma Surgery Survey: Neurosurgical Centers and Pituitary Adenomas
por: Netuka, David, et al.
Publicado: (2022)

Endothelial cell-specific molecule-1 as an invasiveness marker for pituitary null cell adenoma
por: Wang, Shousen, et al.
Publicado: (2019)

PROGNOSTIC ROLE OF CD44 EXPRESSION AND NEOVASCULARIZATION DETERMINED BY ENDOGLIN (CD105) IN GLIOBLASTOMA PATIENTS
por: Mihić, Josip, et al.
Publicado: (2019)

Antagonizing CD105 enhances radiation sensitivity in prostate cancer
por: Madhav, Anisha, et al.
Publicado: (2018)

Data from a comparative proteomic analysis of tumor-derived lung-cancer CD105(+) endothelial cells
por: Jin, Hongwei, et al.
Publicado: (2016)

Molecular pathways of early CD105-positive erythroid cells as compared with CD34-positive common precursor cells by flow cytometric cell-sorting and gene expression profiling
por: Machherndl-Spandl, S, et al.
Publicado: (2013)

CD105 overexpression mediates drug-resistance in choriocarcinoma cells through BMP9/Smad pathway
por: Wang, Xiaoyu, et al.
Publicado: (2020)

Pituitary Crooke Cell Adenoma: Two Cases of an Aggressive Pituitary Adenoma
por: Taiwo, Adeyinka, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_q26saptfvbr9fg1356vnovb5rh